Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic continue to expand worldwide. The article focused on the broad
spectrum antifungal itraconazole as antiviral prodrug with its possible
role against SARS-CoV-2, via immunomodulation, anti-inflammatory
actions, and direct role on the virus non-structural proteins